How common dietary fats change gut bacteria and metabolic markers
Official title: Effects Of Dietary Fats on Gut Microbiota Composition and Metabolic Activity in Healthy Adults
Run by University of Glasgow · NCT07550023 · Data updated 2026-11-12
We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 50 Years |
| Sex | All |
| Enrollment | 64 (estimated) |
| Sponsor | University of Glasgow Academic / other |
| Locations | 1 site (Glasgow) |
| Status | Recruiting |
| Started | March 23, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT07550023 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are generally healthy, non-smoking adults aged 20–50 with BMI 20–30, stable weight, living in the Glasgow area, without recent antibiotic use and not taking medications or supplements that affect the gut or metabolism.
✕Probably not a fit
People with chronic gastrointestinal, metabolic, cardiovascular, hepatobiliary, or pancreatic disease, diagnosed diabetes, recent antibiotic use, lipid‑lowering therapy, fat malabsorption, recent major GI surgery, restrictive diets, relevant food allergies/intolerances, pregnant or lactating, or post‑menopausal women are unlikely to be suitable or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel pilot trial will enrol 64 healthy adults (age 20–50, BMI 20–30) in the Glasgow area and randomize them to one of four fat groups (butter, coconut oil, extra virgin olive oil, sunflower oil) with 60 mL consumed daily for two weeks following a one-week run-in. Stool and fasting blood samples are collected at baseline (Day 1), mid-intervention (Day 7), and post-intervention (Day 22) to measure short-chain fatty acids, microbiota composition, blood lipids, and inflammatory markers. The primary aim is to see whether fats that differ in chain length and saturation produce different microbial fermentation patterns and systemic metabolic effects. All visits take place at the New Lister Building, University of Glasgow.
Why it matters
Potential benefit: If successful, the results could identify which commonly eaten fats promote healthier gut microbial activity and more favourable blood lipid or inflammatory profiles, helping to guide dietary advice.
How similar studies have gone: Prior in vitro work and some human studies suggest dietary fat composition can influence the microbiome and SCFA production, but direct randomized comparisons of multiple common fats with both microbiome and cardiometabolic endpoints in healthy adults are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 20-50 years * Body mass index (BMI) between 20 and 30 kg/m² * Generally healthy * Stable body weight (±2 kg) over the past 2 months * Living in the Glasgow area * Non-smoker Exclusion Criteria: * Use of antibiotics within the past 3 months * Current use of medications affecting gut microbiota or cardiometabolic health * Regular use of dietary supplements that may influence study outcomes (e.g. probiotics, prebiotics, vitamins, minerals, fish oil), unless willing to discontinue prior to study start * Presence of chronic gastrointestinal, metabolic, cardiovascular, hepatobiliary, or pancreatic disease * History of major gastrointestinal surgery * Diagnosed diabetes or use of lipid-lowering therapy * Known fat malabsorption disorders * Pregnant or lactating women * Post-menopausal women * Following a restrictive or specific diet (e.g. vegan, ketogenic diet) * Food allergies or intolerances relevant to study interventions (e.g. dairy, coconut) * Recent significant weight change (±2 kg in the past month) * High reliance on ready meals or takeaway foods (\>7 main meals per week) * Participation in another research study that may interfere with this study
Where it's running
-
New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, G31 2ER
Glasgow, United Kingdom Recruiting
Study contacts
- Principal investigator: Athanasios Koutsos — University of Glasgow
- Study coordinator: Linah Alhomidan
- Email: linahalhomidan@gmail.com
- Phone: +447473477395
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How vitamin C affects gut bacteria and their activity in healthy adults
This study will test whether taking a moderate (200 mg) then a high (1000 mg) daily dose of vitamin C changes gut bacteria composition and short-chain fatty acid levels in healthy adults.
-
Predicting Heart Muscle Recovery After CTO Revascularization
This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.
-
Barley and kefir to support gut health in active adults
This study tests whether a daily barley and kefir meal for four weeks can change gut microbiota in physically active adults and whether those changes relate to certain metabolites in blood and urine.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
Ginger capsules for inflammation, oxidative stress, and blood vessel health
This trial will test whether taking a daily ginger capsule for 60 days can lower inflammation and oxidative stress and improve blood vessel function in adults with excess body fat.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.